Article
Tumour gene expression signature in primary melanoma predicts long-term outcomes: A…
medRxiv · 2020 · Garg, M.; Courturier, D.-L.; Nsengimana, J.; Fonseca, N. A.; Wongchenko, M.; Yan, Y.; Lauss, M.; Jönsson, G. B.; Newton-Bishop, J.; Parkinson, C.; Middleton, M. R.; Bishop, T.; Corrie, P.; Adams, D. J.; Brazma, A.; Rabbie, R.
Key facts
| Title | Tumour gene expression signature in primary melanoma predicts long-term outcomes: A prospective multicentre study |
|---|---|
| First author | Garg, M.; Courturier, D.-L.; Nsengimana, J.; Fonseca, N. A.; Wongchenko, M.; Yan, Y.; Lauss, M.; Jönsson, G. B.; Newton-Bishop, J.; Parkinson, C.; Middleton, M. R.; Bishop, T.; Corrie, P.; Adams, D. J.; Brazma, A.; Rabbie, R. |
| Journal | medRxiv |
| Published | Feb 25, 2020 |
| DOI | 10.1101/2020.02.24.961771 |
| Product codes mentioned | PFT |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1